AGIO
Agios Pharmaceuticals Inc

2,935
Mkt Cap
$2.12B
Volume
918,660.00
52W High
$46.00
52W Low
$22.24
PE Ratio
-4.00
AGIO Fundamentals
Price
$28.19
Prev Close
$28.48
Open
$28.67
50D MA
$27.86
Beta
1.10
Avg. Volume
862,174.58
EPS (Annual)
-$7.12
P/B
1.40
Rev/Employee
$100,051.85
$763.78
Loading...
Loading...
News
all
press releases
Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AGIO
Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AGIO Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc...
PR Newswire·17h ago
News Placeholder
More News
News Placeholder
Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIO
Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIO Agios Pharmaceuticals, Inc...
PR Newswire·2d ago
News Placeholder
Agios Pharmaceuticals Teases 2026 Catalysts as PYRUKYND Thalassemia Launch Gains Early Traction
Agios Pharmaceuticals (NASDAQ:AGIO) executives highlighted multiple upcoming clinical and regulatory milestones during the 46th Annual TD Cowen Healthcare Conference, while also discussing early...
MarketBeat·2d ago
News Placeholder
Vanguard Group Inc. Sells 77,143 Shares of Agios Pharmaceuticals, Inc. $AGIO
Vanguard Group Inc. trimmed its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 1.4% during the 3rd quarter, according to its most recent 13F filing with the...
MarketBeat·3d ago
News Placeholder
Erste Asset Management GmbH Purchases 438,411 Shares of Agios Pharmaceuticals, Inc. $AGIO
Erste Asset Management GmbH lifted its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 18.8% in the 3rd quarter, according to its most recent 13F filing with the SEC...
MarketBeat·6d ago
News Placeholder
Agios Pharmaceuticals (NASDAQ:AGIO) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell?
Agios Pharmaceuticals (NASDAQ:AGIO) Share Price Crosses Below 200 Day Moving Average - Time to Sell...
MarketBeat·7d ago
News Placeholder
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer
Key PointsCommodore Capital sold 2,338,287 shares of Agios Pharmaceuticals in the fourth quarter...
Nasdaq News: Markets·10d ago
News Placeholder
Eagle Health Investments LP Sells 84,600 Shares of Agios Pharmaceuticals, Inc. $AGIO
Eagle Health Investments LP trimmed its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 25.6% in the 3rd quarter, according to its most recent disclosure with the SEC...
MarketBeat·15d ago
News Placeholder
Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash
Key PointsRock Springs Capital Management sold 159,379 Agios Pharmaceuticals shares in the fourth quarter; the estimated trade size was $5.59 million based on average fourth-quarter prices...
Nasdaq News: Markets·15d ago
News Placeholder
HC Wainwright Issues Positive Estimate for AGIO Earnings
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - HC Wainwright boosted their Q1 2026 earnings per share (EPS) estimates for Agios Pharmaceuticals in a report issued on Thursday, February...
MarketBeat·17d ago
<
1
2
...
>

Latest AGIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.